Market Value328,094,000
Total Holdings43
File Date2019-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ODT / Odonate Therapeutics Inc
FGEN / FibroGen, Inc.
AQST / Aquestive Therapeutics, Inc.
ACOR / Acorda Therapeutics, Inc.
KURA / Kura Oncology, Inc.
MRTX / Mirati Therapeutics, Inc.
EPZM / Epizyme Inc
QURE / uniQure N.V.
THOR / Synthorx Inc
CMRX / Chimerix, Inc.
CBAY / CymaBay Therapeutics, Inc.
PLX / Protalix BioTherapeutics, Inc.
HZNP / Horizon Therapeutics Plc
ZYME / Zymeworks Inc.
RARX / Ra Pharmaceuticals, Inc.
ABEO / Abeona Therapeutics Inc.
CMTA / Clementia Pharmaceuticals Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
ESTA / Establishment Labs Holdings Inc.
NVTA / Invitae Corporation
BOLD / Boundless Bio, Inc.
SWAV / Shockwave Medical, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
FBIO / Fortress Biotech, Inc.
AXGN / Axogen, Inc.
LJPC / La Jolla Pharmaceutical Co.
SBBP / Strongbridge Biopharma plc
MGTA / Magenta Therapeutics Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
TCDA / Tricida Inc
US28249H1041 / Eidos Therapeutics, Inc.
ARQL / ArQule, Inc.
0HBB / Aimmune Therapeutics Inc
DERM / Journey Medical Corporation
DCPH / Deciphera Pharmaceuticals, Inc.
CDTX / Cidara Therapeutics, Inc.
AWH / Aspira Women's Health Inc.
AVTX / Avalo Therapeutics, Inc.
XOMA / XOMA Royalty Corporation
ARVN / Arvinas, Inc.
VKTX / Viking Therapeutics, Inc.
FWBI / First Wave BioPharma, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
ATXI / Avenue Therapeutics, Inc.
FENC / Fennec Pharmaceuticals Inc.
FOMX / Foamix Pharmaceuticals Ltd.
BHVN / Biohaven Ltd.
CYTK / Cytokinetics, Incorporated
TVTX / Travere Therapeutics, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
BLRX / BioLineRx Ltd. - Depositary Receipt (Common Stock)
CARA / Cara Therapeutics, Inc.
CDXS / Codexis, Inc.
OCUL / Ocular Therapeutix, Inc.
BPMC / Blueprint Medicines Corporation
LQDA / Liquidia Corporation
PTCT / PTC Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
ETON / Eton Pharmaceuticals, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
HROW / Harrow, Inc.